Related Experiment Video

Updated: Jul 9, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Healthcare-associated pneumonia: principles and emerging concepts on management

Alexandra Chroneou1, Nikolaos Zias, John F Beamis

  • 1Lahey Clinic Medical Center, Department of Pulmonary and Critical Care Medicine, Burlington, Massachusetts 01805, USA.

Expert Opinion on Pharmacotherapy
|November 27, 2007
PubMed

Insights

Healthcare-associated pneumonia (HCAP) management requires careful consideration of multi-drug resistant bacteria. New strategies are needed for effective HCAP treatment in diverse healthcare settings.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Antimicrobial Stewardship

Background:

  • Healthcare-associated pneumonia (HCAP) encompasses infections outside acute-care hospitals.
  • Patients with HCAP face increased risk from multi-drug resistant (MDR) bacteria, including Pseudomonas aeruginosa, ESBL-producing Gram-negative bacilli, and MRSA.
  • MDR pathogen infections necessitate distinct empiric antibiotic regimens.

Purpose of the Study:

  • To review and address HCAP management strategies.
  • To highlight the need for updated principles beyond existing 2005 guidelines.
  • To consider applicability in various long-term care settings.

Main Methods:

  • Literature review of HCAP management principles.
  • Analysis of 2005 American Thoracic Society and Infectious Diseases Society of America guidelines.
  • Discussion of challenges in nursing homes and long-term care facilities.

Main Results:

  • Existing guidelines may not fully apply to all HCAP patients, particularly in long-term care.
  • Inappropriate antibiotic therapy can lead to poorer patient outcomes.
  • Tailored management strategies are crucial for HCAP.

Conclusions:

  • Effective HCAP management requires updated principles considering MDR pathogens.
  • Strategies must be adapted for different healthcare settings, including long-term care.
  • Optimizing empiric antibiotic therapy is key to improving patient outcomes in HCAP.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...